Diastolic Heart Failure: A Separate Disease or Selection Bias?

Progress in Cardiovascular Diseases

Volumn 49, Issue 4, 2007, Pages 275-283

  De Keulenaer, Gilles W ^a,b   Brutsaert, Dirk L ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEREDITY; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; SEX DIFFERENCE; SITTING; SYSTOLIC HEART FAILURE;

AGED; AGED, 80 AND OVER; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; CLINICAL TRIALS; DIASTOLE; FEMALE; HUMANS; MALE; RESEARCH DESIGN; RISK FACTORS; SELECTION BIAS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 33845481384     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2006.08.002     Document Type: Article

References (31)

1. Brutsaert D.L. Diastolic heart failure: perception of the syndrome and scope of the problem. Prog. Cardiovasc. Dis. (2006) [in press]
2. Skaluba S.J., and Litwin S.E. Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation 109 (2004) 972-977
3. Zile M.R., Baicu C.F., and Gaasch W.H. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med. 350 (2004) 1953-1959
4. van Heerebeek L., Borbely A., Niessen H.W., et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113 (2006) 1966-1973
5. Brutsaert D.L. Cardiac dysfunction in heart failure: the cardiologist's love affair with time. Prog. Cardiovasc. Dis. (2006) [in press]
6. Zile M.R., Gaasch W.H., Carroll J.D., et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?. Circulation 104 (2001) 779-782
7. Little W.C. Diastolic dysfunction beyond distensibility: adverse effects of ventricular dilatation. Circulation 112 (2005) 2888-2890
8. Klapholz M., Maurer M., Lowe A.M., et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J. Am. Coll. Cardiol. 43 (2004) 1432-1438
9. CHARM Investigators and Committees, Yusuf S., and Pfeffer M.A. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781
10. The Merit-HF study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
11. Leinwand L.A. Sex is a potent modifier of the cardiovascular system. J. Clin. Invest. 112 (2003) 302-307
12. Carroll J.D., Carroll E.P., Feldman T., et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86 (1992) 1099-1107
13. Shizukuda Y., and Buttrick P.M. Isoprotrenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation 105 (2002) E9
14. Krumholz H.M., Larson M., and Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am. J. Cardiol. 72 (1993) 310-313
15. Weinberg E.O., Thienelt C.D., Katz S.E., et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J. Am. Coll. Cardiol. 34 (1999) 264-273
16. Gardner J.D., Brower G.L., and Janicki J.S. Gender differences in cardiac remodeling secondary to chronic volume overload. J. Card. Fail. 8 (2002) 101-107
17. Jain M., Liao R., Podesser B.K., et al. Influence of gender on the response to hemodynamic overload after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H2544-H2550
18. Camper-Kirby D., Welch S., Walker A., et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ. Res. 88 (2001) 1020-1027
19. Guerra S., Leri A., Wang X., et al. Myocyte death in the failing human heart is gender dependent. Circ. Res. 85 (1999) 856-866
20. Solomon S.D., St John Sutton M., Lamas G.A., et al. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction. Circulation 106 (2002) 1251-1255
21. Parodi G., Carrabba N., Santoro G.M., et al. Heart failure and left ventricular remodeling after reperfused acute myocardial infarction in patients with hypertension. Hypertension 47 (2006) 706-710
22. Mule G., Nardi E., Cottone S., et al. Influence of metabolic syndrome on hypertension-related target organ damage. J. Intern. Med. 257 (2005) 503-513
23. Giunti S., Bruno G., Veglio M., et al. Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study. Diabetes Care 28 (2005) 2255-2257
24. Grandi A.M., Maresca A.M., Giudici E., et al. Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. Am. J. Hypertens. 19 (2006) 199-205
25. Poornima I.G., Parikh P., and Shannon R.P. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ. Res. 98 (2006) 596-605
26. Brancaccio M., Fratta L., Notte A., et al. Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat. Med. 9 (2003) 68-75
27. Hirota H., Chen J., Betz U.A., et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97 (1999) 189-198
28. Owan T.E., Hodge D.O., Herges R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355 (2006) 251-259
29. Douglas P.S., Katz S.E., Weinberg E.O., et al. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J. Am. Coll. Cardiol. 32 (1998) 1118-1125
30. Tenenbaum A., Fisman E.Z., Schwammenthal E., et al. Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus. Cardiovasc. Diabetol. 2 (2003) 14
31. Tenenbaum A., Fisman E.Z., and Motro M. Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovasc. Diabetol. 2 (2003) 4